files/journal/2022-09-03_18-51-40-000000_599.png

Research Journal of Medical Sciences

ISSN: Online 1993-6095
ISSN: Print 1815-9346

References

  1. Ma, J.F. and L.M.D. Shortliffe, 2004. Urinary tract infection in children: Etiology and epidemiology. Urologic Clin. North Am., 31: 517-526.
  2. American College of Obstetricians and Gynecologists, 2008. ACOG practice bulletin No. 91: Treatment of urinary tract infections in nonpregnant women. Obstet. Gynecol., 111: 785-794.
  3. Foxman, B., B. Gillespie, J. Koopman, L. Zhang and K. Palin et al., 2000. Risk factors for second urinary tract infection among college women. Am. J. Epidemiol., 151: 1194-1205.
  4. Schnarr, J. and F. Smaill, 2008. Asymptomatic bacteriuria and symptomatic urinary tract infections in pregnancy. Eur. J. Clin. Invest., 38: 50-57.
  5. Nguyen, H.T., 2004. Bacterial Infections of the Genitourinary Tract. In: Smith’s General Urology., Tanagho, E.A. and J.W. McAninch, (Eds.)., McgrawHill Medical, New York, ISBN-13: 0-07-159331-4, pp: 193-218.
  6. Momoh, A.R., 2011. The antibiogram types of Escherichia coli isolated from suspected urinary tract infection samples. J. Microbiol. Biotech. Res., 1: 57-65.
  7. Seman, A., S. Sebre, T. Awoke, B. Yeshitela and A. Asseffa et al., 2021. The Magnitude of Carbapenemase and ESBL Producing Enterobacteriaceae Isolates from Patients with Urinary Tract Infections at Tikur Anbessa Specialized Teaching Hospital, Addis Ababa, Ethiopia. In: Advances in Microbiology, Infectious Diseases and Public Health., Donelli, G., (Ed.)., Springer International Publishing, Cham, ISBN-27: 9783031019944,9783031019951, pp: 117-128.
  8. World Medical Association, 2013. World medical association declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA, 310: 2191-2194.
  9. Mathur, R., 2017. National Ethical Guidelines for Biomedical and Health Research Involving Human Participants. Indian Council of Medical Research, New Delhi, ISBN-16: 978-81-910091-94, Pages: 187.
  10. Jadeja, B., N. Khokhar and G. Shrimali, 2023. Risk factors for extended-spectrum beta-lactamase- and carbapenem- resistant Enterobacteriaceae in patients with urinary tract infection from a tertiary care hospital. Nat. J. Physiol., Pharm. Pharmacol., 13: 1304-1307.
  11. Ahmed, O., A. Omar, A. Asghar and M. Elhassan, 2013. Increasing prevalence of esbl-producing enterobacteriaceae in Sudan community patients with utis. Egypt. Acad. J. Bio. Sci., G. Microbiol., 5: 17-24.
  12. Modi, C.M., S.P. Singh, Y.G. Pandya, C.P. Patel and R.M. Patel, 2021. Prevalence of carbapenem resistant enterobacteriaceae in a tertiary care hospital of gujarat, India. J. Clin. Diagn. Res., Vol. 273. 10.7860/jcdr/2021/47332.14627.
  13. Eshetie, S., C. Unakal, A. Gelaw, B. Ayelign, M. Endris and F. Moges, 2015. Multidrug resistant and carbapenemase producing enterobacteriaceae among patients with urinary tract infection at referral hospital, Northwest Ethiopia. Antimicrob. Resist. Infec. Control, Vol. 4. 10.1186/s13756-015-0054-7.
  14. Sasirekha, B., 2013. Prevalence of ESBL, AmpC β-lactamases and MRSA among uropathogens and its antibiogram. EXCLI J., 30: 81-88.
  15. Nair, P.K. and M.S. Vaz, 2013. Prevalence of carbapenem resistant Enterobacteriaceae from a tertiary care hospital in Mumbai, India. J. Microbiol. Infect. Dis., 3: 207-210.
  16. Jayakaran, J., N. Soundararajan and P. Shanmugam, 2019. Phenotypic and genotypic characterization of multidrug-resistant isolates from patients with catheter-associated urinary tract infection in a tertiary care hospital. J. Lab. Physicians, 11: 206-211.